https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » Ireland
Nabriva secures Xenleta FDA approval for community-acquired pneumonia

Nabriva secures Xenleta FDA approval for community-acquired pneumonia

Xenleta FDA approval : Irish pharma company Nabriva Therapeutics has bagged approval from the US Food and Drug Administration for its semi-synthetic pleuromutilin antibiotic Xenleta (lefamulin) for the treatment of community-acquired bacterial pneumonia in adults. Community-acquired pneumonia is caused when someone develops pneumonia in the community, that is not in a hospital. Pneumonia is a […]

Jazz Pharmaceuticals acquires Cavion, developer of essential tremor drugs

Jazz Pharmaceuticals acquisition of Cavion : Irish pharma company Jazz Pharmaceuticals has acquired US-based clinical-stage pharma company Cavion, a developer of essential tremor drugs, in a deal worth up to $312.5 million as per the latest pharma acquisition news. Based in Cambridge, Massachusetts, Cavion is engaged in developing therapies aimed at regulating the T-type calcium […]

Continue reading …
AbbVie to acquire Botox developer Allergan for $63bn

AbbVie acquisition of Allergan : US biopharma company AbbVie is all set to acquire Botox developer Allergan, an Irish pharma company, for $63 billion in a cash cum stock deal, as per pharma acquisition news. Headquartered in Chicago, AbbVie is engaged in developing drugs in areas such as immunology, oncology, neuroscience, and virology. On the […]

Continue reading …
Takeda acquisition of Shire : Japanese pharma company completes $62bn acquisition

Takeda acquisition of Shire : Japanese pharma company Takeda Pharmaceutical wrapped up its previously announced acquisition of Shire, an Irish biotech company with a focus on rare diseases, for $62 billion, as per the latest pharma acquisition news. Takeda acquisition of Shire It was in May 2018 when Takeda agreed to acquire the Irish rare […]

Continue reading …
Allergan acquisition of Bonti : Allergan to acquire US aesthetic company in $195m deal

Allergan acquisition of Bonti : Irish pharma company Allergan will acquire Bonti, a US aesthetic company, engaged in the development of fast-acting neurotoxin programs for aesthetic and therapeutic applications, in a deal worth over $195 million. Allergan Acquisition of Bonti | US Aesthetic Company in $195m Deal As per the terms of the Allergan acquisition […]

Continue reading …
Alkermes to evaluate ALKS 4230, pembrolizumab combo for solid tumors

Irish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS 4230 to assess its safety and anti-tumor activity in combination with Merck’s PD-1 inhibitor KEYTRUDA (pembrolizumab) in advanced solid tumors. According to Alkermes, ALKS 4230 is an engineered fusion protein which selectively binds and signals […]

Continue reading …